(1 - 26 von 30
)
Mistellektine kontra Tumorzellen | Pharmazeutische Zeitung
www.pharmazeutische-zeitung.de
... so Professor Dr. Hans-Herbert Fiebig, Geschäftsführer der Oncotest GmbH, Freiburg. Sein Unternehmen prüfte das Mistellektin an verschiedenen humanen
Back-to-the-Future with Tumor Cell-Based AvatarsGenetic Engineering and Biotechnology News
www.genengnews.com
— Conceived by Heinz-Herbert Fiebig and colleagues at the University of Freiburg in the early 1980s, it was hoped that PDX mice would more ...
Biotest AG: Further preclinical studies emphasise the potential of...
www.eqs-news.com
The studies were undertaken by Oncotest GmbH in Freiburg, an independent research laboratory Prof. Dr. Heinz-Herbert Fiebig. "I have ...
Mice were implanted with Rob Ford's tumor in bid to save him
www.statnews.com
But it was too time-consuming and impractical to use for patients, Dr. Heinz-Herbert Fiebig of Germany's University of Freiburg concluded, and ...
sortiert nach Relevanz / Datum